Qiming Venture Partners

Qiming Venture Partners, established in 2006, is a leading China-based venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong, and Singapore. It manages multiple funds totaling $9.5 billion, focusing on early and growth-stage investments in the Technology and Consumer (T&C) and Healthcare industries. With a strong track record, over 200 portfolio companies have achieved exits, and over 70 have become unicorns or super unicorns. Qiming Venture Partners USA, founded in 2017, is its affiliate in Cambridge, Massachusetts, specializing in healthcare, therapeutics, and digital health investments. The firm is known for its deep technical expertise, hands-on operational support, and thought leadership in the venture capital industry.

Zhang Ao

Executive Director

Artavazd Arumov Ph.D

Principal

Ryan Baker

CFO

Cyrus Chan

Associate

Nan Chen

Principal

David Chu

Partner

Isaac Ciechanover

Partner

Phil DiGiacomo

Principal

Anna French

Managing Partner

Yuxin Fu

Vice President

Jinda Gao

Principal

Kuantai Yeh

Partner

Robert Headley

Partner

Maykin Ho

Venture Partner

William Hu

Managing Partner

Duane Kuang

Co-Founder and Managing Partner

Nisa Leung

Managing Partner

Dingzheng Li

Vice President

Bin Liu

Vice President

Jing Liu

Vice President

Chang Liu

Associate

Biao Lu

Associate

Shuo Mao

Principal

Will McConnell

Principal

Gary Rieschel

Managing Partner

James Shen

Venture Partner

Motao Sun

Vice President

Amy Tang

Venture Partner

Yi Tang

Principal

Shiyu Wang

Partner

Rachel Wang

Venture Partner

James Wang

Venture Partner

Xu Gillian

RMB funds CFO

Peter (Ming) Yin

Principal, Cleantech

Janet Yu

Partner

Oscar Zhang

Principal

Zhiyuan Zhou

Associate

Alex Zhou

Managing Partner

Yafeng Zhou

Associate

Zhifeng Zhou

Managing Partner

Phillip DiGiacomo Ph.D

Principal

Jing-Shan Hu Ph.D

Venture Partner of Healthcare

Past deals in Scale Stage

TOPI Imaging Technology

Series E in 2025
TOPI Imaging Technology is a medical device firm providing OCT retinal diagnostic system and sweep optical biometer.

IntoCare

Series D in 2024
IntoCare is a high-tech company specializing in surgical products such as "Smart" powered staplers.

Zhipu AI

Series D in 2024
Zhipu AI is a data company focused on developing an AI-based large model platform that offers API services tailored to various customer needs. The company provides a range of smart application products, including the scientific and technological information analysis engine "AMiner" and AI cognitive engines such as CodeGeeX and CogView. These tools are designed to help users automate and optimize digital tasks, thereby reducing the required manual labor. Zhipu AI's advanced applications are built on its General Language Model (GLM) series, capable of handling tasks in both Chinese and English, making its offerings versatile and applicable across different linguistic contexts.

SinoUnited Health

Series D in 2024
SinoUnited Health is a medical center based in Shanghai, China, specializing in sports medicine, physical therapy, pain management, orthopedics, and neurology services. Established in 2004, the center offers a wide range of treatments, including services for foot and ankle issues, acupuncture, chronic pain, movement disorders, migraines, tremors, electromyography, balance training, home exercise programs, manual therapy, post-stroke care, post-herpetic neuralgia, osteoarthritis, and carpal tunnel syndrome. Known for its commitment to high-quality patient care, SinoUnited Health integrates thoughtful design with international standards to enhance the patient experience. The center has built a strong reputation for delivering reliable diagnoses and effective treatment outcomes, ensuring high levels of customer satisfaction among both local residents and visitors.

DK Medtech

Series E in 2024
DK Medtech is a medical technology company based in Suzhou, China, specializing in the development and production of balloon catheter medical devices. Founded in 2015, the company has positioned itself as a leader in the medical device industry, focusing on innovative solutions to address complex healthcare challenges. Through its commitment to excellence, DK Medtech aims to improve patient outcomes and enhance the quality of healthcare.

Emulate

Series F in 2024
Emulate, Inc. is a biotechnology company specializing in organs-on-chips technology that emulates human biology to enhance the understanding of diseases, medicines, chemicals, and food impacts on human health. The company develops organ-chips that replicate normal organ functions as well as various disease states, primarily targeting the lung, intestine, liver, and skin. Emulate's innovative human emulation system provides researchers with advanced in vitro models that offer more precise and detailed predictions of human responses compared to traditional experimental methods, such as cell culture or animal testing. The company serves a diverse range of markets, including biotechnology, pharmaceuticals, consumer health, cosmetics, chemicals, food, agrochemicals, government agencies, and academic research. Founded in 2013 and based in Boston, Massachusetts, Emulate was previously known as Emulate Living MicroDevices, Inc. before rebranding in July 2014.

Dr.Clear Aligner

Series F in 2024
Dr.Clear is an oral invisible orthodontic solution service provider that specializes in offering safe and comfortable digital solutions for face development management and invisible dental correction for children and adolescents.

Xiaoe Tech

Series D in 2024
Xiaoe Tech is a technology service provider that specializes in new education, offering a variety of software solutions and services tailored for different industries. The company develops SaaS tools for knowledge payment, including enterprise training, cloud services, and content distribution. Its offerings support content entrepreneurs and educational institutions by providing essential resources such as data, traffic management, and consulting. Xiaoe Tech's products facilitate brand communication, traffic growth, classroom management, and student engagement, ultimately enabling a streamlined approach to business monetization in the education sector. By focusing on both tools and strategic support, Xiaoe Tech helps clients build and manage their online knowledge dissemination platforms effectively.

Wecare Probiotics

Series D in 2023
Wecare Probiotics is a national high-tech enterprise focused on the research and development, production, and application of probiotic strains. The company offers a diverse range of probiotic products, including fermented food strains and beneficial microbial flora, suitable for various industries such as food, healthcare, and medicine. By prioritizing quality and efficiency, Wecare Probiotics aims to deliver effective solutions that meet the needs of its customers.

Huimei Technology

Series D in 2023
Huimei Technology is a National high-tech enterprise that offers medical artificial intelligence solutions.

IntoCare

Series D in 2023
IntoCare is a high-tech company specializing in surgical products such as "Smart" powered staplers.

Caidya

Series D in 2023
Caidya is a clinical research organization based in North Carolina, founded in 2021. The company specializes in providing personalized solutions across various therapeutic areas and focuses on enhancing clinical development capabilities. Caidya operates a proprietary technology platform that integrates data from multiple systems to deliver near real-time insights into clinical trials. Additionally, it offers advisory services related to clinical development plans, regulatory strategies, approval processes, and clinical trial support. By facilitating the globalization of innovative drugs and improving clinical trial efficiency, Caidya aims to increase the likelihood of success for biopharmaceutical and medical companies.

Insilico Medicine

Series D in 2022
Insilico Medicine, Inc. is a biotechnology company that leverages artificial intelligence (AI) to transform drug discovery, biomarker development, and aging research. Founded in 2014 and based in Baltimore, Maryland, the company has established itself as a pioneer in applying advanced AI techniques, such as generative adversarial networks and reinforcement learning, to create novel molecular structures for various diseases, including cancer and age-related conditions. Insilico Medicine operates an integrated platform that covers all stages of drug discovery, from initial research to clinical trial analysis. Its projects include Pharma.AI, which offers machine learning services to various sectors, and Young.AI, a platform focused on aging predictors. The company also pursues internal drug discovery initiatives targeting diseases like Alzheimer's and Parkinson's, and has partnered with Life Extension to produce nutraceutical products utilizing deep learning and bioinformatics. Additionally, Insilico Medicine provides consumer applications aimed at enhancing health and longevity.

Ark Biosciences

Series D in 2022
Ark Biosciences Inc. is a biopharmaceutical company based in Shanghai, China, specializing in the discovery and development of therapeutics aimed at addressing unmet medical needs, particularly in the areas of respiratory viral infections and viral hepatitis. Founded in 2013, the company focuses on developing innovative treatments, including AK0701 for chronic obstructive pulmonary disease, AK0529 for respiratory syncytial virus, AK0612 for influenza, and AK0705 and AK0706 for hepatitis B. Ark Biosciences is committed to advancing antiviral drug research and development to serve both global and Chinese markets.

Insilico Medicine

Series D in 2022
Insilico Medicine, Inc. is a biotechnology company that leverages artificial intelligence (AI) to transform drug discovery, biomarker development, and aging research. Founded in 2014 and based in Baltimore, Maryland, the company has established itself as a pioneer in applying advanced AI techniques, such as generative adversarial networks and reinforcement learning, to create novel molecular structures for various diseases, including cancer and age-related conditions. Insilico Medicine operates an integrated platform that covers all stages of drug discovery, from initial research to clinical trial analysis. Its projects include Pharma.AI, which offers machine learning services to various sectors, and Young.AI, a platform focused on aging predictors. The company also pursues internal drug discovery initiatives targeting diseases like Alzheimer's and Parkinson's, and has partnered with Life Extension to produce nutraceutical products utilizing deep learning and bioinformatics. Additionally, Insilico Medicine provides consumer applications aimed at enhancing health and longevity.

Booming Technologies

Series D in 2022
Booming Tech is a cloud-based platform that specializes in game development and virtual reality. It provides tools for creators to design and innovate within virtual environments, catering to various applications, including gaming, industrial simulations, and other immersive experiences. The platform features a robust server architecture that ensures players can engage in real-time, stable interactions regardless of their geographical locations. By focusing on both entertainment and practical applications, Booming Tech supports a diverse range of virtual world creation, enabling users to explore new possibilities in digital interaction.

Shanzhen

Series D in 2021
ShanZhen is a health service platform focused on addressing the physical health and pension needs of individuals born in the 1980s and 1990s. The company provides affordable regular health checkups, personalized health management plans, and insurance options. Additionally, it offers medical examination services and data finance products aimed at mitigating the challenges posed by an aging population and the rising prevalence of chronic diseases. Through its comprehensive services, ShanZhen seeks to enhance the quality of life for elderly patients, promoting healthier and happier living conditions.

Petkit

Series D in 2021
Shanghai PETKIT Network Technology Co., Ltd., founded in 2013, specializes in developing and manufacturing innovative pet care products. Based in Shanghai, China, the company offers a diverse range of smart devices designed to enhance the health and well-being of pets. Its product lineup includes smart feeders, antibacterial bowls, drinking fountains, and pet monitoring devices that track activity levels, calorie consumption, and overall health. Additionally, Petkit provides a mobile application that integrates with its smart devices, allowing pet owners to monitor their pets' behaviors and health metrics conveniently. By combining technology with pet care, Petkit aims to simplify pet management for owners while ensuring the welfare of their animals.

NEIWAI

Series D in 2021
NEIWAI is a mid-to-high-end underwear brand founded in Shanghai in 2012, dedicated to providing comfortable clothing that respects the feelings of women. The company emphasizes a design philosophy that harmonizes comfort, function, and beauty, resulting in a diverse range of products suitable for various daily activities, including home and sports. Over the past five years, NEIWAI has served more than 200,000 female customers, reflecting its commitment to meeting the needs of its clientele. By focusing on the comfort of close-fitting clothing, NEIWAI aims to enhance the everyday experiences of its customers through thoughtfully designed underwear.

Insight Lifetech

Series D in 2021
Insight Lifetech is a medical technology company focused on developing and manufacturing innovative solutions for the diagnosis and treatment of cardiovascular diseases. The company has established a comprehensive platform that integrates research and development, manufacturing, and commercialization, facilitating collaboration across its operations. This synergy accelerates product development, enhances cost-efficiency, and fosters innovation. Notably, Insight Lifetech developed the first domestic fractional flow reserve (FFR) system in China, which received approval from the National Medical Products Administration. Through its high-quality medical devices and advanced technologies, the company aims to provide reliable precision in cardiovascular diagnosis and therapy, ultimately enabling physicians to save and improve patients' lives.

Xiaoe Tech

Series D in 2021
Xiaoe Tech is a technology service provider that specializes in new education, offering a variety of software solutions and services tailored for different industries. The company develops SaaS tools for knowledge payment, including enterprise training, cloud services, and content distribution. Its offerings support content entrepreneurs and educational institutions by providing essential resources such as data, traffic management, and consulting. Xiaoe Tech's products facilitate brand communication, traffic growth, classroom management, and student engagement, ultimately enabling a streamlined approach to business monetization in the education sector. By focusing on both tools and strategic support, Xiaoe Tech helps clients build and manage their online knowledge dissemination platforms effectively.

Hesai Technology

Series D in 2021
Hesai Technology is a company based in Shanghai, China, founded in 2014. It specializes in designing laser radar systems using smart sensing technology. The primary application of these systems is to facilitate autonomous driving by enabling car companies to monitor mixed gas composition and detect hazardous leaks. Additionally, Hesai Technology develops natural gas leak detection systems for industrial processes. Its LiDAR products are used in a variety of applications including advanced driver assistance systems (ADAS), autonomous vehicle fleets, last-mile delivery robots, street sweeping robots, and logistics robots. The company operates through two main segments: the LiDAR segment and the gas detection segment, with the former being the primary revenue generator.

LetsGetChecked

Series D in 2021
LetsGetChecked is a healthcare technology company that facilitates at-home health testing. It connects users with regulated laboratories worldwide for various tests, including general wellness, sexual health, women's health, men's health, and COVID-19. Users collect samples at home using provided kits and mail them back for analysis; results are then accessible online. The platform aims to empower individuals to proactively manage their health, offering services across the United States, Canada, and Europe.

IntoCare

Series D in 2021
IntoCare is a high-tech company specializing in surgical products such as "Smart" powered staplers.

Unisound

Series D in 2021
Beijing Yunzhisheng Information Technology Co., Ltd., also known as Unisound, is a Chinese startup established in June 2012, specializing in intelligent voice and speech processing technologies. The company has developed proprietary speech recognition technologies and utilizes cloud computing to deliver a range of middleware and cloud platforms for speech recognition services. Unisound's offerings cater to both internet enterprises and individual users, providing professional solutions for voice recognition. The core technology team is composed of highly qualified professionals, with over 80% holding doctoral degrees and possessing extensive experience in voice recognition research and development. Additionally, Unisound focuses on Internet of Things (IoT) and artificial intelligence (AI) technologies, enabling efficient communication between users and machines through voice commands, thereby minimizing the need for manual input.

Delta Medical

Series E in 2021
Beijing Delta Medical Co., Ltd. specializes in the design and manufacture of orthopedic surgical instruments and rehabilitation products. The company offers a range of products, including shoulder arthroscopic instruments, various types of suture anchors, instruments for anterior and posterior cruciate ligament reconstruction, interference screws, and shaver systems. In addition to its surgical instruments, Delta Medical provides sports rehabilitation services. The company is headquartered in Beijing, China, and focuses on delivering innovative solutions in sports medicine.

XSKY Data Technology

Series E in 2021
XSKY Data Technology, based in Beijing, specializes in software-defined infrastructure products and services. It offers a range of storage solutions, including XCBS (cloud), XEBS (block), XEUS (unified), XEOS (object), and XEDP (unified data platform), catering to diverse sectors such as finance, telecom, energy, and government. XSKY is a significant contributor to the open-source Ceph storage system, ranking top 3 globally. It partners with leading tech companies like Intel and Samsung, providing scalable, cost-effective storage solutions tailored for enterprise needs.

Beijing Yuan Xin

Series E in 2021
Beijing Yuanxin is a technology company that offers an integrated healthcare platform for pharmaceutical distribution and health insurance.

Miaoshou Doctor

Series E in 2021
Miaoshou Doctor is a healthcare service platform established in 2015 by Tao He and Daoliang Han, headquartered in Beijing. The company focuses on facilitating communication between patients and healthcare professionals, enabling effective management of post-diagnosis outcomes. Its platform empowers doctors to actively monitor their patients' health through ongoing counseling and prescription support, enhancing the overall patient care experience. By streamlining interactions and follow-ups, Miaoshou Doctor aims to improve health outcomes and foster better relationships between patients and their healthcare providers.

Erwan Technology

Series D in 2021
Erwan Technology is an online education provider based in Dalian Shi, Liaoning, China, specializing in financial investment education for Chinese middle-class families. Founded in 2016, the company has established itself as the largest online investment education platform in terms of user base, reaching over 10 million students across 34 provincial administrative regions. Erwan Technology offers a diverse array of paid educational modules, including live broadcasts, boutique investment courses, and hands-on workshops, designed to impart essential financial skills. The platform covers various financial topics, such as investment strategies, risk management, and wealth management, thereby equipping its viewers with fundamental financial knowledge. Its commitment to popularizing financial education has positioned it among the top three platforms in revenue within the industry.

Erwan Technology

Series E in 2021
Erwan Technology is an online education provider based in Dalian Shi, Liaoning, China, specializing in financial investment education for Chinese middle-class families. Founded in 2016, the company has established itself as the largest online investment education platform in terms of user base, reaching over 10 million students across 34 provincial administrative regions. Erwan Technology offers a diverse array of paid educational modules, including live broadcasts, boutique investment courses, and hands-on workshops, designed to impart essential financial skills. The platform covers various financial topics, such as investment strategies, risk management, and wealth management, thereby equipping its viewers with fundamental financial knowledge. Its commitment to popularizing financial education has positioned it among the top three platforms in revenue within the industry.

Abbisko Therapeutics

Series D in 2021
Abbisko Therapeutics Co. Ltd. is a clinical-stage biopharmaceutical company based in Shanghai, China, focused on the discovery, development, and manufacturing of innovative immuno-oncology therapies. Founded in 2016 by a team of experienced professionals from leading pharmaceutical companies, Abbisko is dedicated to developing small molecule inhibitors, including ABSK011 and ABSK021, for the treatment of hepatocellular carcinoma, as well as CSF1R for solid tumors. In addition to oncology, the company is engaged in developing therapeutics for various conditions, including cancer, liver diseases, diabetes, metabolic disorders, viral infections, and central nervous system diseases.

MicroTech Medical

Series D in 2020
MicroTech Medical, founded in January 2011 in Hangzhou Future Technical City, is a company focused on the research, development, and manufacturing of innovative and affordable medical devices for diabetes care. The firm specializes in creating both treatment and monitoring devices aimed at improving diabetes management, primarily serving the Chinese market while also reaching international customers. With significant backing from Eli Lilly and Company, MicroTech Medical is dedicated to enhancing the quality of life for individuals living with diabetes through advanced technology solutions.

Viewtrix Technology

Series D in 2020
Viewtrix Technology specializes in the development of display driver chips and circuit boards, focusing on enhancing display resolution and color representation across various types of screens, including OLED, LCD, and LED. The company’s technologies are designed to support a range of electronic devices such as mobile phones, tablets, and notebooks. By providing advanced display solutions, Viewtrix Technology enables electronics manufacturers to improve the quality of their products while simultaneously reducing costs.

Yunyinggu

Series D in 2020
Yunyinggu Technology Co., Ltd. is a Chinese start-up focused on the development and promotion of innovative display technologies aimed at enhancing the performance of flat panel displays. The company has created a proprietary solution recognized for achieving superior pixel density, or high pixels per inch (PPI), which can be utilized across various types of flat panels, including LCD, LED, and OLED displays. By advancing display technology, Yunyinggu seeks to contribute to the evolving landscape of visual performance in consumer electronics.

Asieris Pharmaceuticals

Series D in 2020
Asieris Pharmaceuticals Co. Ltd. is a biotechnology company based in Taizhou, China, founded in 2010. The company is dedicated to the research and development of pharmaceutical products aimed at treating tumors and addressing multidrug-resistant infections. By focusing on oncology and infectious diseases, Asieris Pharmaceuticals seeks to develop innovative therapies that meet the medical needs of patients both in China and globally.

InventisBio

Series D in 2020
InventisBio Inc. is a biotechnology company focused on discovering and developing innovative therapeutics for cancer and metabolic diseases. Founded in 2013 and based in Pudong, China, the company has developed a range of small molecule drug candidates targeting lung cancer, breast cancer, and gout. Among its notable products is D-0316, a third-generation EGFR-T790M tyrosine kinase inhibitor. InventisBio is also engaged in creating targeted immuno-oncology therapies that can be used in combination with existing treatments, such as PD-1 antibodies, to address various cancer indications. Co-founded by Dr. Yaolin Wang and a team of scientists with extensive experience in drug discovery at major pharmaceutical companies, InventisBio aims to provide effective therapies for significant health challenges.

Delta Medical

Series D in 2020
Beijing Delta Medical Co., Ltd. specializes in the design and manufacture of orthopedic surgical instruments and rehabilitation products. The company offers a range of products, including shoulder arthroscopic instruments, various types of suture anchors, instruments for anterior and posterior cruciate ligament reconstruction, interference screws, and shaver systems. In addition to its surgical instruments, Delta Medical provides sports rehabilitation services. The company is headquartered in Beijing, China, and focuses on delivering innovative solutions in sports medicine.

New Horizon Health

Series E in 2020
New Horizon Health is a biotechnology company based in Hangzhou, China, with an additional office in Beijing, specializing in the development of innovative technologies for early cancer detection and screening. Founded in 2015, the company primarily focuses on gastrointestinal cancers, offering products such as the ColoClear and Pupu Tube, which utilize fecal gene analysis (FIT-DNA) technology for colorectal cancer screening. These products enable users to conduct in-home tests, allowing for the early detection of colon cancer and precancerous lesions that may not be identified through traditional blood tests. New Horizon Health aims to reduce cancer morbidity and mortality rates by promoting accessible and efficient health services, leveraging big data and artificial intelligence in its screening technologies. The company's commitment to early cancer screening reflects its mission to enhance public health by facilitating widespread access to vital diagnostic tools.

XSKY Data Technology

Series D in 2020
XSKY Data Technology, based in Beijing, specializes in software-defined infrastructure products and services. It offers a range of storage solutions, including XCBS (cloud), XEBS (block), XEUS (unified), XEOS (object), and XEDP (unified data platform), catering to diverse sectors such as finance, telecom, energy, and government. XSKY is a significant contributor to the open-source Ceph storage system, ranking top 3 globally. It partners with leading tech companies like Intel and Samsung, providing scalable, cost-effective storage solutions tailored for enterprise needs.

Miaoshou Doctor

Series D in 2020
Miaoshou Doctor is a healthcare service platform established in 2015 by Tao He and Daoliang Han, headquartered in Beijing. The company focuses on facilitating communication between patients and healthcare professionals, enabling effective management of post-diagnosis outcomes. Its platform empowers doctors to actively monitor their patients' health through ongoing counseling and prescription support, enhancing the overall patient care experience. By streamlining interactions and follow-ups, Miaoshou Doctor aims to improve health outcomes and foster better relationships between patients and their healthcare providers.

Beijing Yuan Xin

Series D in 2020
Beijing Yuanxin is a technology company that offers an integrated healthcare platform for pharmaceutical distribution and health insurance.

New Horizon Health

Series D in 2020
New Horizon Health is a biotechnology company based in Hangzhou, China, with an additional office in Beijing, specializing in the development of innovative technologies for early cancer detection and screening. Founded in 2015, the company primarily focuses on gastrointestinal cancers, offering products such as the ColoClear and Pupu Tube, which utilize fecal gene analysis (FIT-DNA) technology for colorectal cancer screening. These products enable users to conduct in-home tests, allowing for the early detection of colon cancer and precancerous lesions that may not be identified through traditional blood tests. New Horizon Health aims to reduce cancer morbidity and mortality rates by promoting accessible and efficient health services, leveraging big data and artificial intelligence in its screening technologies. The company's commitment to early cancer screening reflects its mission to enhance public health by facilitating widespread access to vital diagnostic tools.

Club Factory

Series D in 2019
Club Factory is an online shopping platform that facilitates cross-border e-commerce by connecting consumers directly with manufacturers. By leveraging big data and artificial intelligence, the company scans the internet to identify factories that sell products on various platforms such as Wish, eBay, and Amazon. This allows Club Factory to compare prices from multiple sources, ultimately presenting customers with the lowest available prices. In addition to enhancing the shopping experience for consumers, the company also provides supply chain management solutions for enterprises, enabling them to optimize their operations and improve cost efficiency.

DST Car

Series D in 2019
DiShangTie Car Rental (Shenzhen) Co., Ltd. is a company based in Shenzhen, China, specializing in the rental and maintenance of commercial electric vehicles (EVs) for passenger and cargo transportation. Established in 2015, the company focuses on the transportation and logistics sector, providing sustainable energy vehicle rental services tailored for the new energy logistics market. DiShangTie also manufactures electric car charging stations, supporting its commitment to offering green and sustainable vehicle leasing alternatives to major express logistics and urban distribution companies. Through its services, the company aims to facilitate the adoption of environmentally friendly transport solutions in China.

Shanzhen

Series D in 2019
ShanZhen is a health service platform focused on addressing the physical health and pension needs of individuals born in the 1980s and 1990s. The company provides affordable regular health checkups, personalized health management plans, and insurance options. Additionally, it offers medical examination services and data finance products aimed at mitigating the challenges posed by an aging population and the rising prevalence of chronic diseases. Through its comprehensive services, ShanZhen seeks to enhance the quality of life for elderly patients, promoting healthier and happier living conditions.

Bondent

Series D in 2019
Bondent Technology Co., Ltd., headquartered in Shanghai, China, specializes in supplying dental equipment and materials. It offers a comprehensive range of services, including technical training, operational and management consulting, decoration design, and financial solutions. Bondent's core business involves the design, development, manufacturing, and sales of oral medical equipment, creating a full ecosystem for the dental and oral health industry.

Mafengwo

Series E in 2019
Mafengwo is a prominent Chinese travel social networking site that facilitates the sharing of travel experiences among users. The platform boasts over one million entries of user-generated travel guides and more than five million ratings and reviews, catering to a diverse array of travel-related needs, including information on hotels, flights, travel routes, visas, and insurance. Since its inception, Mafengwo has served over 25 million users, emphasizing user experience by continually enhancing its social platform for sharing travel information. Its core product, the Travel Guide, encompasses more than 95% of global travel destinations and has surpassed 100 million downloads. In 2012, Mafengwo expanded its offerings by integrating booking services from major platforms such as Booking, Agoda, Ctrip, and eLong, further solidifying its position in the travel industry.

Nuvaira

Series E in 2019
Nuvaira, Inc. is a medical device company based in Minneapolis, Minnesota, focused on developing innovative treatments for obstructive lung diseases, particularly chronic obstructive pulmonary disease (COPD). Founded in 2008, Nuvaira specializes in a novel catheter-based Lung Denervation System that aims to address airway nerve hyperactivity by targeting the parasympathetic innervation of the lungs. This minimally invasive procedure is designed to improve lung function, enhance exercise capacity, and elevate the quality of life for patients suffering from chronic respiratory conditions. With a commitment to advancing treatment options, Nuvaira seeks to reduce the clinical consequences associated with neural hyperactivity in conditions such as COPD and asthma.

Schrödinger

Series E in 2019
Schrödinger is a healthcare-focused software company that specializes in computational drug design, serving pharmaceutical and biotechnology research sectors. Established in 1990, it offers a powerful computational platform that aids biopharmaceutical and industrial companies, as well as academic and government institutions, in their research efforts globally. Schrödinger operates through two main segments: Software and Drug Discovery. The Software segment supplies solutions aimed at enhancing the drug discovery process across the life sciences and materials science industries. Meanwhile, the Drug Discovery segment generates revenue through a portfolio of preclinical and clinical programs, both independently and through collaborative efforts. The company is committed to advancing science and talent to support its platform and has over 400 employees, engaging with customers and collaborators in more than 70 countries.

Yi Technology

Series D in 2018
YI Technology is a prominent international developer of advanced imaging technologies, specializing in smart, wearable, and mobile video products. The company is recognized for its innovative contributions to the imaging sector, including the launch of the first action camera capable of recording 4K60 video with extended recording times. YI Technology's product lineup encompasses a variety of devices such as smart home cameras, sports cameras, driving recorders, mirrorless cameras, smart retail boxes, and face capture machines. The company leverages cutting-edge technologies, including computer vision algorithms, deep learning, and advanced face recognition systems, to deliver high-performance, high-quality vision products at competitive prices. Through its focus on intelligent electronic products, YI Technology enables clients to enhance their imaging experiences with sophisticated technology.

AoHua

Series D in 2018
Aohua is a global provider of endoscopy devices and solutions, focused on advancing endoscope technology and enhancing diagnostic and treatment capabilities in endoscopy. Founded in 1994 and based in Shanghai, China, the company specializes in the research, development, production, and sales of electronic endoscope equipment, along with associated diagnostic and surgical consumables. Aohua aims to lead innovation in endoscopic technology, contributing to the overall progress of medical endoscopy practices.

Tuhu

Series E in 2018
Tuhu is a prominent integrated online and offline platform for automotive services in China, catering to car owners' diverse needs through a customer-centric model. The company offers same-day or next-day delivery and installation of automobile after-sales products in over 260 cities across mainland China. Tuhu's services are accessible via its website, mobile app, call center, and third-party e-commerce platforms. By streamlining its supply chain and providing a digitalized, on-demand service experience, Tuhu effectively connects car owners, suppliers, and automotive service stores. Its platform accommodates a wide range of passenger vehicle models and fulfills various automotive service demands, including tire and chassis parts replacement, maintenance, repair, and detailing.

Micropoint Bio

Series E in 2018
MicroPoint Bioscience, Inc. is a Chinese company focused on the research and development of biochips. It specializes in the manufacturing of point-of-care testing (POCT) equipment and biological diagnostic test reagent cards, primarily for medical applications. The company's Lab On a Chip product series leverages micro-electronic mechanical systems (MEMS) to offer advanced microfluidic bio-diagnostic testing solutions. These innovations facilitate early diagnosis and monitoring of critical health issues, including vascular diseases and tumors. MicroPoint Bioscience customizes its products and services to meet the needs of various sectors, including human health, environmental protection, food safety, and scientific research, thereby contributing to improved healthcare outcomes and operational efficiency in medical settings.

Wacai.com

Series D in 2018
Wacai is a Chinese mobile app developer specializing in personal finance management through its widely-used mobile application. Since its launch in 2009, the app has provided users with bookkeeping services and expanded its functionality to include mutual fund trading in 2013. In 2014, Wacai introduced a credit card manager feature, which has become increasingly popular among users in China. The app aims to help individuals manage their finances effectively by offering tools for personal bookkeeping, credit management, and an online community for financial assistance. With a user base exceeding 40 million, Wacai continues to enhance its platform to meet the evolving needs of its clientele.

Xueba100.com

Series D in 2018
Xueba100 is an educational platform that caters to K-12 students in China, specializing in providing software and online services designed to assist junior and senior high school students with their studies. The platform offers a "super scholar" feature that allows students to upload images of challenging homework questions and receive detailed answers and procedures. This service leverages advanced technology, including STR Technology and deep learning models, to enhance character recognition and improve the accuracy of responses. In addition to its homework assistance, Xueba100 collaborates with experienced instructors to create customized curricula across various subjects, delivering comprehensive educational resources and test preparation tools to support students' learning needs.

ACEA Biosciences

Series E in 2018
ACEA Biosciences, Inc., established in 2002 and headquartered in San Diego, California, specializes in developing and commercializing microelectronic sensor systems for cell-based assays, drug discovery, and diagnostics. The company's flagship product, the x-CELLigence System, offers real-time, label-free cell analysis, serving diverse applications such as cell proliferation, cytotoxicity testing, and receptor function monitoring. ACEA's products cater to science research and drug discovery markets, with over 800 customers worldwide and numerous peer-reviewed publications. The company operates a state-of-the-art manufacturing facility in Hangzhou, China, and serves its global customer base as a subsidiary of Agilent Technologies, Inc.

Chushou

Series D in 2018
Chushou is a Chinese social networking platform that specializes in live video streaming, primarily focused on mobile gaming. The platform hosts approximately 2.7 million live streaming broadcasters, with around 150,000 active hosts engaging daily. Chushou allows gamers to interact with one another while live streaming their mobile gaming activities, creating a dynamic environment for both broadcasters and viewers. Through its mobile-based services, Chushou facilitates a unique community for gamers, fostering interaction and engagement within the gaming ecosystem.

Mafengwo

Series D in 2017
Mafengwo is a prominent Chinese travel social networking site that facilitates the sharing of travel experiences among users. The platform boasts over one million entries of user-generated travel guides and more than five million ratings and reviews, catering to a diverse array of travel-related needs, including information on hotels, flights, travel routes, visas, and insurance. Since its inception, Mafengwo has served over 25 million users, emphasizing user experience by continually enhancing its social platform for sharing travel information. Its core product, the Travel Guide, encompasses more than 95% of global travel destinations and has surpassed 100 million downloads. In 2012, Mafengwo expanded its offerings by integrating booking services from major platforms such as Booking, Agoda, Ctrip, and eLong, further solidifying its position in the travel industry.

Iron Armour

Series D in 2017
Iron Armour is China TOP 1 online service platform in construction equipment industry. We focus on equipment trading services & equipment management, and we offer diversity choice and service to our customer, which including consignment service, online auction , web portal, and equipment management based on IoT.

Iron Armour

Series D in 2017
Iron Armour, founded in 2009 by CEO Fan Construction, operates a platform dedicated to the sale of second-hand construction machinery. The company aims to facilitate the buying and selling of used equipment, serving users in the engineering machinery sector globally. Iron Armour's platform provides industry information and enables online communication, promoting transparency and access within the market. Committed to enhancing the development of China's construction machinery industry, Iron Armour leverages the internet to connect buyers and sellers, thereby fostering industry progress.

Lagou

Series D in 2017
Lagou.com is a Beijing-based recruitment website that specializes in staffing services, primarily focusing on the technology and internet sectors. Founded in 2013, it provides a platform for job seekers to find employment in various fields, including IT, design, data operations, marketing, sales, and game development. The company has established a strong client base that includes major industry players such as Tencent, Baidu, Alibaba Group, SINA, JD.com, and Beijing Xiaomi Tech. By connecting qualified candidates with leading companies, Lagou.com plays a significant role in facilitating recruitment in China's competitive job market.

Meituan Bike

Series E in 2017
Meituan Bike, previously known as Mobike, is a Chinese bicycle-sharing service that operates a fully station-less model. Founded in January 2015 by Davis Wang Xiao Feng, Hu Wei Wei, and Xia Yi Ping, the company is headquartered in Beijing. Meituan Bike allows users to easily locate and rent bicycles through a mobile application, facilitating convenient transportation for short urban trips. The bicycles are equipped with smart locks and can be reserved via the app, offering a seamless user experience. In April 2018, the company was acquired by Meituan-Dianping for $2.7 billion and was rebranded as Meituan Bike in January 2019 as part of the integration process. The service has grown significantly since its inception, contributing to the development of urban mobility solutions in China.

CanSinoBIO

Series E in 2017
CanSino Biologics Inc. is a biotechnology company based in Tianjin, China, focused on the research, development, manufacturing, and commercialization of vaccines. The company is actively developing a range of vaccines, including those for Ebola, meningitis, pertussis, and pneumococcal diseases, with multiple candidates currently in various phases of clinical trials. Notable products under development include the recombinant coronavirus vaccine Ad5-nCov, as well as several preclinical stage vaccines targeting adenovirus, Zika virus, meningitis, shingles, and polio. CanSino collaborates with the National Research Council of Canada to advance COVID-19 vaccine initiatives and has a co-development agreement with Precision NanoSystems to create an mRNA lipid nanoparticle vaccine against COVID-19. Founded in 2009, CanSino aims to meet the unmet medical needs in China and other emerging markets by providing high-quality vaccines at affordable prices.

ByteDance

Series D in 2017
ByteDance is a technology company that develops and operates a range of content platforms, most notably TikTok and Douyin. It aims to enhance user experiences through innovative technology, allowing individuals to connect, create, and consume content seamlessly. The company specializes in mobile applications that cater to online media, entertainment, and social networking, leveraging artificial intelligence to deliver personalized content that aligns with users' preferences. In addition to its flagship platforms, ByteDance provides tools that facilitate content creation and collaboration, reflecting its commitment to enriching lives through technology.

Zhihu

Series D in 2017
Zhihu is a prominent Chinese social question-and-answer platform that allows users to seek information by soliciting opinions and insights from individuals rather than relying solely on traditional forum responses. Established to foster a community-driven exchange of knowledge, Zhihu has grown significantly, with a registered user base exceeding 300,000 by early 2012. The company operates primarily within the online content community space, monetizing its services through a combination of paid memberships, advertising, content-commerce solutions, and vocational training offerings. All of its revenue is generated from within China, reflecting its focus on the domestic market and its commitment to providing users with a rich and engaging platform for knowledge sharing.

CooTek

Series D in 2017
CooTek, founded in 2008 and headquartered in Shanghai, is a global mobile internet company that specializes in developing innovative mobile applications and artificial intelligence technologies. The company is best known for its flagship app, TouchPal Keyboard, which enhances input experiences for users on both Android and iPhone devices. CooTek's diverse portfolio includes content-rich applications across various categories, such as online literature, mobile games, and scenario-based apps focused on fitness, healthcare, and lifestyle. With a significant presence in the United States, CooTek has achieved a broad user base, boasting an average of 213.7 million monthly active users globally as of September 2018. The company is committed to technological innovation, holding over 170 patents and actively pursuing advancements in artificial intelligence through its dedicated AI lab and big data development center in Silicon Valley. CooTek's research has been recognized in prominent discussions at major big data and AI conferences.

Meituan Bike

Series D in 2017
Meituan Bike, previously known as Mobike, is a Chinese bicycle-sharing service that operates a fully station-less model. Founded in January 2015 by Davis Wang Xiao Feng, Hu Wei Wei, and Xia Yi Ping, the company is headquartered in Beijing. Meituan Bike allows users to easily locate and rent bicycles through a mobile application, facilitating convenient transportation for short urban trips. The bicycles are equipped with smart locks and can be reserved via the app, offering a seamless user experience. In April 2018, the company was acquired by Meituan-Dianping for $2.7 billion and was rebranded as Meituan Bike in January 2019 as part of the integration process. The service has grown significantly since its inception, contributing to the development of urban mobility solutions in China.

Shenogen Pharma Group

Series D in 2017
Shenogen Pharma Group is a drug discovery and development company.

OneAPM

Series D in 2016
OneAPM is a Beijing-based provider of IT operation and maintenance management software and services, founded in 2008. The company focuses on delivering integrated intelligent solutions for enterprise users in China, aiming to enhance the efficiency of IT operations. Its software encompasses real-time performance monitoring for servers and network applications, as well as a comprehensive resource operation and maintenance platform. By offering these services, OneAPM helps businesses streamline their operations and improve overall performance. The company is dedicated to its mission of making IT operation and maintenance more intelligent, thereby supporting enterprises in achieving their operational goals.

CooTek

Series D in 2016
CooTek, founded in 2008 and headquartered in Shanghai, is a global mobile internet company that specializes in developing innovative mobile applications and artificial intelligence technologies. The company is best known for its flagship app, TouchPal Keyboard, which enhances input experiences for users on both Android and iPhone devices. CooTek's diverse portfolio includes content-rich applications across various categories, such as online literature, mobile games, and scenario-based apps focused on fitness, healthcare, and lifestyle. With a significant presence in the United States, CooTek has achieved a broad user base, boasting an average of 213.7 million monthly active users globally as of September 2018. The company is committed to technological innovation, holding over 170 patents and actively pursuing advancements in artificial intelligence through its dedicated AI lab and big data development center in Silicon Valley. CooTek's research has been recognized in prominent discussions at major big data and AI conferences.

ACEA Biosciences

Series E in 2016
ACEA Biosciences, Inc., established in 2002 and headquartered in San Diego, California, specializes in developing and commercializing microelectronic sensor systems for cell-based assays, drug discovery, and diagnostics. The company's flagship product, the x-CELLigence System, offers real-time, label-free cell analysis, serving diverse applications such as cell proliferation, cytotoxicity testing, and receptor function monitoring. ACEA's products cater to science research and drug discovery markets, with over 800 customers worldwide and numerous peer-reviewed publications. The company operates a state-of-the-art manufacturing facility in Hangzhou, China, and serves its global customer base as a subsidiary of Agilent Technologies, Inc.

Qiniu

Series D in 2016
Qiniu Cloud is a leading enterprise cloud service provider in China. It is committed to driving social industry development with cloud technology, and it focuses on the cloud computing industry with data intelligence and visual intelligence as its core. Through massive data and rich media scenarios across industries, Qiniu Cloud launches the intelligent video cloud integrated with CDN, object storage, cloud host, big data, content recognition platform and other product portfolios, which provides comprehensive cloud computing service for users. More than one million enterprise-level clients are using qiniu cloud to provide services for 80% of the Internet users nationwide. It provides cloud plus smart technology empowerment for users in various industries to meet the new opportunities of Artificial Intelligence and the arrival of 5G era.

Shenogen Pharma Group

Series D in 2015
Shenogen Pharma Group is a drug discovery and development company.

Mitralign

Series E in 2015
Mitralign is a privately held medical device company based in a suburb of Boston, Massachusetts. It specializes in developing catheter-based technologies for the percutaneous treatment of functional mitral regurgitation, a global and life-threatening cardiac condition. The company's innovative Mitralign system mimics surgical annuloplasty by delivering a series of implants directly into the mitral annulus via a catheter, reducing its size and improving valve function. Mitralign is backed by top-tier venture capitalists and has strategic investments from major cardiovascular device companies.

LanzaTech

Series D in 2014
LanzaTech, Inc. is a carbon recycling company based in Skokie, Illinois, with additional offices in Roselle, Illinois; Shanghai, China; and Gurgaon, India. Founded in 2005, the company specializes in producing fuel ethanol from renewable non-food resources, including industrial flue gases and waste gases generated from municipal solid waste and biomass gasification. LanzaTech’s innovative technology converts carbon emissions into valuable products, effectively retrofitting industrial emission sources, such as steel mills, to create sustainable fuels, fabrics, and packaging. By recycling carbon from various sources, the company aims to displace a significant portion of crude oil use and contribute to a circular carbon economy, ultimately reducing global CO2 emissions. LanzaTech's approach not only addresses the carbon crisis but also provides a pathway for sustainable consumer goods.

MOGU

Series D in 2014
MOGU is an online fashion and lifestyle platform based in China, primarily targeting women. The company offers a diverse array of fashion content and products through its various platforms, including Mogujie.com, Meilishuo.com, and Mogu.com, as well as mobile applications and WeChat Mini programs. MOGU enables users to discover and share the latest fashion trends while enjoying an enhanced shopping experience. The platform features multimedia content such as live video broadcasts, short-form videos, and photography, catering to a wide range of interests and age groups. In addition to its e-commerce offerings, MOGU provides online marketing, commission services, and technology support to merchants and brands, thereby facilitating a comprehensive ecosystem for both consumers and businesses within the fashion industry.

Crown Bioscience

Series D in 2014
Crown Bioscience International, through its subsidiary Crown Bioscience Inc., is a global company specializing in drug discovery and development solutions. Founded in 2006 and based in Taipei, Taiwan, the company focuses on providing translational platforms for oncology, cardiovascular, and metabolic diseases, helping biopharmaceutical companies enhance drug efficacy and patient response while minimizing clinical failures. Crown Bioscience offers a comprehensive range of products, including antibodies for in vivo and in vitro studies, recombinant proteins, and tumor tissue microarrays, as well as integrated preclinical testing services. The firm has established strategic partnerships, including collaborations with the Shanghai Model Organisms Center and Hubrecht Organoid Technology, to advance its capabilities in genetically engineered models and organoid-based preclinical drug development. With facilities in the United States, United Kingdom, China, and Taiwan, Crown Bioscience serves the biotech and pharmaceutical industries worldwide, facilitating the acceleration of new drug development programs.

Novast

Series D in 2011
Novast Holdings Ltd. is a multinational pharmaceutical company headquartered in China and the United States, specializing in the research, development, and manufacturing of FDA-inspected generic drugs. The company is recognized for its expertise in designing challenging formulations and drug delivery systems, focusing on value-added generics with controlled release and various dosage types. Novast collaborates with pharmaceutical and biotechnology firms to commercialize products for regulated markets, positioning itself as a key player in the U.S. pharmaceutical sector. With cGMP manufacturing facilities spanning 18,000 square meters, Novast has a management team experienced in applying numerous generic drug patents in the U.S. and possesses a strong foundation in innovative drug development technologies. Its unique capabilities in addressing diverse research, development, and manufacturing needs distinguish Novast within the industry.

VANCL

Series F in 2011
VANCL is a Chinese retail company founded in 2007 by Chen Nian, headquartered in Beijing. It specializes in online sales of modern apparel, accessories, footwear, luggage, and textiles at competitive prices. The company offers a diverse range of products, including men's shirts, women's and children's clothing, T-shirts, trousers, dresses, shoes, and various accessories such as bags, belts, and sunglasses. In addition to its online platform, VANCL also operates physical stores, providing customers with multiple shopping options. The company's focus on quality and affordability has positioned it as a prominent player in the Chinese retail market.

CITIC Pharmaceutical

Series D in 2009
CITIC Pharmaceutical Co., Ltd. (中信医药) is a pharmaceutical service provider that supplies medicine and related consumables to hospitals. It is a large pharmaceutical operation enterprise integrating medicines supply to hospitals, cross-regional commercial distribution, vaccine sale, medical instruments and consumables sale, and medicine retailing service. In recent years, it has become a pharmaceutical service provider in the supply chain with multiple customized integration service. CITIC Pharmaceutical, which is a subsidiary of CITIC Group, was transformed to a joint venture in 2007. It is invested by China Health System whose holding company is Bioveda China fund and CITIC Investment Holdings Ltd.

ChinaCache

Series D in 2009
ChinaCache is a prominent Chinese provider of content delivery networks and cloud-based services, established in 1998. The company caters to a diverse range of clients, including small and large enterprises, luxury brands, e-commerce platforms, banking institutions, online gaming, and media organizations. With a robust infrastructure that includes over 400 service nodes in more than 120 major cities across China, ChinaCache offers a total network capacity exceeding 1000Gbps. The company maintains interconnections with all major telecommunications carriers and local internet service providers in Mainland China, enabling it to enhance online services and user experiences for its clients. All of ChinaCache's revenue is generated within the People's Republic of China, underscoring its focus on the domestic market.

VANCL

Series D in 2008
VANCL is a Chinese retail company founded in 2007 by Chen Nian, headquartered in Beijing. It specializes in online sales of modern apparel, accessories, footwear, luggage, and textiles at competitive prices. The company offers a diverse range of products, including men's shirts, women's and children's clothing, T-shirts, trousers, dresses, shoes, and various accessories such as bags, belts, and sunglasses. In addition to its online platform, VANCL also operates physical stores, providing customers with multiple shopping options. The company's focus on quality and affordability has positioned it as a prominent player in the Chinese retail market.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.